VF
ZVRA icon

Virtu Financial’s Zevra Therapeutics ZVRA Stock Holding History

Virtu Financial’s Portfolio ZVRA Stock Details ZVRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-62,740
Closed -$597K – 2330
2025
Q3 		$597K Buy
+62,740
New +$629K 0.03% 489
2024
Q4 		– Sell
-18,367
Closed -$127K – 2145
2024
Q3 		$127K Buy
+18,367
New +$125K 0.01% 870
2024
Q1 		– Sell
-26,966
Closed -$177K – 2198
2023
Q4 		$177K Buy
+26,966
New +$126K 0.01% 877
2023
Q3 		– Sell
-21,893
Closed -$112K – 1993
2023
Q2 		$112K Buy
+21,893
New +$118K 0.01% 1008
2022
Q3 		– Sell
-13,042
Closed -$58K – 2303
2022
Q2 		$58K Sell
13,042
-24,177
-65% -$110K ﹤0.01% 1085
2022
Q1 		$187K Buy
+37,219
New +$237K 0.01% 803
2021
Q3 		– Sell
-71,435
Closed -$916K – 2038
2021
Q2 		$916K Buy
71,435
+33,239
+87% +$357K 0.09% 234
2021
Q1 		$351K Buy
+38,196
New +$334K 0.02% 715
2019
Q4 		– Sell
-1,071
Closed -$12K – 1925
2019
Q3 		$12K Buy
1,071
+425
+66% +$7.68K ﹤0.01% 1335
2019
Q2 		$18K Buy
+646
New +$16.2K ﹤0.01% 1355
2018
Q3 		– Sell
-921
Closed -$96K – 2307
2018
Q2 		$96K Sell
921
-367
-28% -$35.8K 0.01% 1657
2018
Q1 		$163K Buy
+1,288
New +$125K 0.01% 1440
2017
Q4 		– Sell
-903
Closed -$53K – 3108
2017
Q3 		$53K Buy
+903
New +$48.1K ﹤0.01% 2219

Other funds holding ZVRA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

Virtu Financial's ZVRA Position: Q4 2025 in Review

Virtu Financial sold out of Zevra Therapeutics (ZVRA) in Q4 2025, closing a stake of 62,740 shares — an estimated $597K sold.

Virtu Financial first reported a position in ZVRA in Q3 2017 and held it in 13 quarters. The position peaked at $916K in Q2 2021. 158 funds tracked by Wall St. Rank hold ZVRA as of Q4 2025.

  • Virtu Financial reported no remaining Zevra Therapeutics position as of Q4 2025 after selling out during the quarter.
  • Virtu Financial sold 62,740 Zevra Therapeutics shares in Q4 2025, an estimated $597K.
  • Virtu Financial first reported a position in Zevra Therapeutics in Q3 2017 and held it in 13 quarters.
  • Virtu Financial's Zevra Therapeutics position peaked at $916K in Q2 2021.
  • 158 funds tracked by Wall St. Rank held Zevra Therapeutics as of Q4 2025.

Based on Virtu Financial's 13F filing for Q4 2025, filed 23 Feb 2026.